acetazolamide has been researched along with Migraine Disorders in 31 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Episodic ataxia type 2 is an autosomal dominant channelopathy, caused by genetic variants in the voltage-dependent calcium channel a-1 subunit (CACNA1A), which is characterized by intermittent episodes of vertigo and ataxia." | 5.72 | The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2. ( Brieva-Ruiz, L; González-Mingot, C; López-Ortega, R, 2022) |
| "Acetazolamide was prescribed in seven patients; the mean duration of treatment was 6 months, and the daily dose ranged from 125 to 500 mg." | 5.38 | Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. ( Bianchi, S; Donnini, I; Inzitari, D; Nannucci, S; Pantoni, L; Pescini, F; Valenti, R, 2012) |
| "Clinical details are given of different types of episodic ataxia: type 1, with myokymia, and attacks which usually last a few minutes, and may occur several times a day, and treatment with acetazolamide can reduce the number of attacks; type 2, with interictal nystagmus, and attacks which last for several hours to a day or more, and treatment with acetazolamide is very effective; paroxysmal choreoathetosis with episodic ataxia, with attacks lasting for about 20 min and occurring at varying intervals; and familial hemiplegic migraine, with transient hemiplegia presenting during the aura of a migraine headache, the symptoms improving on treatment with acetazolamide." | 4.80 | Episodic ataxia and channelopathies. ( Gordon, N, 1998) |
| "Patients with autism spectrum disorder and developmental delay or encephalopathy rarely demonstrate no or negligible hair and nail growth, suggesting a biotin-responsive clinical disorder." | 3.88 | Biotin and Acetazolamide for Treatment of an Unusual Child With Autism Plus Lack of Nail and Hair Growth. ( Benke, PJ; Duchowny, M; McKnight, D, 2018) |
| "The headache associated with idiopathic intracranial hypertension frequently has a migrainous phenotype." | 2.72 | Diagnosis and treatment of idiopathic intracranial hypertension. ( Hoffmann, J; Raoof, N, 2021) |
| "Familial hemiplegic migraine and episodic ataxia type 2 (EA2) are allelic disorders with distinct types of mutations in the CACNA1A gene." | 2.70 | Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. ( Bousser, MG; Djomby, R; El-Amrani, M; Filipetti, V; Landais, P; Lutz, G; Massiou, H; Taupin, P; Vahedi, K, 2002) |
| "Of 131 women with hormonally related migraines unresponsive to standard medication, 67 (51." | 2.67 | Efficacy of danazol in the control of hormonal migraine. ( Bennett, RS; Daoud, Y; Lichten, EM; Whitty, AJ, 1991) |
| "Episodic ataxia type 2 is an autosomal dominant channelopathy, caused by genetic variants in the voltage-dependent calcium channel a-1 subunit (CACNA1A), which is characterized by intermittent episodes of vertigo and ataxia." | 1.72 | The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2. ( Brieva-Ruiz, L; González-Mingot, C; López-Ortega, R, 2022) |
| "Vestibular migraine (VM) consists of recurrent episodes of vestibular symptoms that are accompanied by migraine in at least 50% of the episodes." | 1.56 | Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug. ( Álvarez-Morujo de Sande, MG; Bécares-Martínez, C; Domènech-Vadillo, E; Domínguez-Durán, E; González-Aguado, R; Guerra-Jiménez, G; Montilla-Ibáñez, MA, 2020) |
| "A presumed diagnosis of episodic ataxia type 2 was made and she became attack free on acetazolamide without recurrence." | 1.51 | A sleep modulated Channelopathy: a novel CACNA1A pathogenic variant identified in episodic Ataxia type 2 and a potential link to sleep alleviated migraine. ( Ahuja, AS; Atwal, PS; Rozen, TD, 2019) |
| "To describe a new subtype of chronic daily headache in women of a specific age group." | 1.48 | A New Subtype of Chronic Daily Headache Presenting in Older Women. ( Rozen, TD, 2018) |
| "Acetazolamide was effective in reducing both the frequency and severity of vertigo and headache attacks and this effect was more prominent for vertigo frequency and severity." | 1.43 | Acetazolamide in vestibular migraine prophylaxis: a retrospective study. ( Bilgen, C; Çelebisoy, N; Gökçay, F; Karahan, C; Karapolat, H; Kirazlı, T; Köse, T, 2016) |
| "We report a child with congenital ataxia, abnormal eye movements and developmental delay who presented severe attacks of hemiplegic migraine triggered by minor head traumas and associated with hemispheric swelling and seizures." | 1.40 | Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A. ( Al-Qusairi, L; Bonafé, L; García Segarra, N; Gautschi, I; Kallay Zetchi, C; Maeder, P; Mittaz-Crettol, L; Roulet-Perez, E; Schild, L; Van Bemmelen, MX, 2014) |
| "Acetazolamide was prescribed in seven patients; the mean duration of treatment was 6 months, and the daily dose ranged from 125 to 500 mg." | 1.38 | Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. ( Bianchi, S; Donnini, I; Inzitari, D; Nannucci, S; Pantoni, L; Pescini, F; Valenti, R, 2012) |
| "Twelve age-matched migraine patients and 14 healthy subjects served as control groups." | 1.32 | The cerebral hemodynamics of headache associated with sexual activity. ( Evers, S; Frese, A; Husstedt, IW; Ringelstein, EB; Schmidt, O, 2003) |
| "Patients suffering from migraine showed a significant increase in global CBF values after acetazolamide provocation (paired t test, P<0." | 1.31 | Quantitative assessment of blood flow reserve using 99mTc-HMPAO in carotid stenosis. ( Bánk, J; Ficzere, A; Galuska, L; Garai, I; Olvasztó, S; Szomják, E; Tóth, C; Varga, J, 2002) |
| "The association of FHM and cerebellar ataxia has been reported in a small number of FHM families, all linked to chromosome 19." | 1.30 | A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. ( Battistini, N; Battistini, S; Carrera, P; Ferrari, M; Gelfi, C; Giannini, F; Guazzi, GC; Piatti, M; Righetti, PG; Rocchi, R; Stenirri, S, 1999) |
| "We report two cases of idiopathic intracranial hypertension causing chronic daily headache with migrainous features in the absence of associated papilledema." | 1.29 | Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension. ( Huff, AL; Hupp, SL; Rothrock, JF, 1996) |
| "Three patients with migraine with aura had less pronounced regional hypoperfusion compared to baseline." | 1.28 | The influence of acetazolamide on cerebral low-flow regions in migraine--an interictal 99mTc-HMPAO SPECT study. ( Böttger, IG; Grotemeyer, KH; Husstedt, IW; Oberwittler, C; Schlake, HP; Schober, O, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 9 (29.03) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 11 (35.48) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| González-Mingot, C | 1 |
| López-Ortega, R | 1 |
| Brieva-Ruiz, L | 1 |
| Ahuja, AS | 1 |
| Rozen, TD | 2 |
| Atwal, PS | 1 |
| Domínguez-Durán, E | 1 |
| Montilla-Ibáñez, MA | 1 |
| Álvarez-Morujo de Sande, MG | 1 |
| Domènech-Vadillo, E | 1 |
| Bécares-Martínez, C | 1 |
| González-Aguado, R | 1 |
| Guerra-Jiménez, G | 1 |
| Raoof, N | 1 |
| Hoffmann, J | 1 |
| Benke, PJ | 1 |
| Duchowny, M | 1 |
| McKnight, D | 1 |
| García Segarra, N | 1 |
| Gautschi, I | 1 |
| Mittaz-Crettol, L | 1 |
| Kallay Zetchi, C | 1 |
| Al-Qusairi, L | 1 |
| Van Bemmelen, MX | 1 |
| Maeder, P | 1 |
| Bonafé, L | 1 |
| Schild, L | 1 |
| Roulet-Perez, E | 1 |
| Ranieri, A | 1 |
| Topa, A | 1 |
| Cavaliere, M | 1 |
| De Simone, R | 1 |
| Mallery, RM | 1 |
| Friedman, DI | 1 |
| Liu, GT | 1 |
| Çelebisoy, N | 1 |
| Gökçay, F | 1 |
| Karahan, C | 1 |
| Bilgen, C | 1 |
| Kirazlı, T | 1 |
| Karapolat, H | 1 |
| Köse, T | 1 |
| Llovet-Rausell, A | 1 |
| Ruiz Tolosa, F | 1 |
| Kudsieh, B | 1 |
| Suzuki, M | 1 |
| Fujiwara, K | 1 |
| Tsubuku, T | 1 |
| Yabe, I | 1 |
| Sasaki, H | 1 |
| Fukuda, S | 1 |
| Altinok, D | 1 |
| Agarwal, A | 1 |
| Ascadi, G | 1 |
| Luat, A | 1 |
| Tapos, D | 1 |
| Donnini, I | 1 |
| Nannucci, S | 1 |
| Valenti, R | 1 |
| Pescini, F | 1 |
| Bianchi, S | 1 |
| Inzitari, D | 1 |
| Pantoni, L | 1 |
| van den Maagdenberg, AM | 1 |
| Plomp, JJ | 1 |
| Evers, S | 1 |
| Schmidt, O | 1 |
| Frese, A | 1 |
| Husstedt, IW | 2 |
| Ringelstein, EB | 1 |
| Helling, K | 1 |
| Scherer, H | 1 |
| Seet, RC | 1 |
| Lim, EC | 1 |
| Mathew, NT | 1 |
| Ravishankar, K | 1 |
| Sanin, LC | 1 |
| Valikovics, A | 1 |
| Oláh, L | 1 |
| Fülesdi, B | 1 |
| Káposzta, Z | 1 |
| Ficzere, A | 2 |
| Bereczki, D | 1 |
| Csiba, L | 1 |
| Huff, AL | 1 |
| Hupp, SL | 1 |
| Rothrock, JF | 1 |
| Athwal, BS | 1 |
| Lennox, GG | 1 |
| Gordon, N | 1 |
| Weller, M | 1 |
| Dichgans, J | 1 |
| Klockgether, T | 1 |
| Battistini, S | 1 |
| Stenirri, S | 1 |
| Piatti, M | 1 |
| Gelfi, C | 1 |
| Righetti, PG | 1 |
| Rocchi, R | 1 |
| Giannini, F | 1 |
| Battistini, N | 1 |
| Guazzi, GC | 1 |
| Ferrari, M | 1 |
| Carrera, P | 1 |
| Forteza, AM | 1 |
| Brozman, B | 1 |
| Rabinstein, AA | 1 |
| Romano, JG | 1 |
| Bradley, WG | 1 |
| Garai, I | 1 |
| Varga, J | 1 |
| Szomják, E | 1 |
| Tóth, C | 1 |
| Bánk, J | 1 |
| Olvasztó, S | 1 |
| Galuska, L | 1 |
| Vahedi, K | 1 |
| Taupin, P | 1 |
| Djomby, R | 1 |
| El-Amrani, M | 1 |
| Lutz, G | 1 |
| Filipetti, V | 1 |
| Landais, P | 1 |
| Massiou, H | 1 |
| Bousser, MG | 1 |
| Schlake, HP | 1 |
| Böttger, IG | 1 |
| Grotemeyer, KH | 1 |
| Oberwittler, C | 1 |
| Schober, O | 1 |
| Lichten, EM | 1 |
| Bennett, RS | 1 |
| Whitty, AJ | 1 |
| Daoud, Y | 1 |
| Siemes, H | 1 |
| Casaer, P | 1 |
3 reviews available for acetazolamide and Migraine Disorders
| Article | Year |
|---|---|
Diagnosis and treatment of idiopathic intracranial hypertension.
Topics: Acetazolamide; Analgesics; Headache; Headache Disorders; Humans; Intracranial Hypertension; Migraine | 2021 |
Headache and the pseudotumor cerebri syndrome.
Topics: Acetazolamide; Back Pain; Diagnosis, Differential; Diuretics; Fructose; Furosemide; Headache Disorde | 2014 |
Episodic ataxia and channelopathies.
Topics: Acetazolamide; Ataxia; Athetosis; Cerebellar Ataxia; Chorea; Hemiplegia; Humans; Ion Channels; Migra | 1998 |
3 trials available for acetazolamide and Migraine Disorders
| Article | Year |
|---|---|
Neuromuscular synapse function in typical migraine.
Topics: Acetazolamide; Adult; Calcium Channels, N-Type; Electromyography; Female; Follow-Up Studies; Humans; | 2003 |
Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial.
Topics: Acetazolamide; Adolescent; Adult; Aged; Bicarbonates; Blood Pressure; Calcium Channels, P-Type; Carb | 2002 |
Efficacy of danazol in the control of hormonal migraine.
Topics: Acetazolamide; Adult; Combined Modality Therapy; Danazol; Drug Therapy, Combination; Female; Humans; | 1991 |
25 other studies available for acetazolamide and Migraine Disorders
| Article | Year |
|---|---|
The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2.
Topics: 4-Aminopyridine; Acetazolamide; Adult; Ataxia; Cerebellar Ataxia; Female; Humans; Male; Middle Aged; | 2022 |
A sleep modulated Channelopathy: a novel CACNA1A pathogenic variant identified in episodic Ataxia type 2 and a potential link to sleep alleviated migraine.
Topics: Acetazolamide; Adult; Ataxia; Calcium Channels; Carbonic Anhydrase Inhibitors; Channelopathies; Codo | 2019 |
Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug.
Topics: Acetazolamide; Amitriptyline; Analgesics; Central Nervous System Agents; Flunarizine; Humans; Migrai | 2020 |
A New Subtype of Chronic Daily Headache Presenting in Older Women.
Topics: Acetazolamide; Cerebrospinal Fluid Pressure; Female; Head-Down Tilt; Headache Disorders; Humans; Mid | 2018 |
Biotin and Acetazolamide for Treatment of an Unusual Child With Autism Plus Lack of Nail and Hair Growth.
Topics: Acetazolamide; Anticonvulsants; Autism Spectrum Disorder; Biotin; Child; Female; Hair Diseases; Huma | 2018 |
Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.
Topics: Acetazolamide; Adolescent; Animals; Ataxia; Brain Edema; Calcium Channels; Cerebellar Ataxia; Child; | 2014 |
Recurrent epistaxis following stabbing headache responsive to acetazolamide.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Chronic Disease; Epistaxis; Female; Headache Disorders | 2014 |
Acetazolamide in vestibular migraine prophylaxis: a retrospective study.
Topics: Acetazolamide; Adult; Aged; Analgesics; Female; Headache; Humans; Male; Middle Aged; Migraine Disord | 2016 |
Severe ocular side effects with acetazolamide: case report.
Topics: Acetazolamide; Acute Disease; Adult; Brimonidine Tartrate; Cyclopentolate; Drug Therapy, Combination | 2016 |
Time course of downbeat positioning nystagmus in familial hemiplegic migraine type 1 treated with acetazolamide.
Topics: Acetazolamide; Anticonvulsants; Cerebellar Ataxia; Family Health; Humans; Magnetic Resonance Imaging | 2016 |
Pediatric hemiplegic migraine: susceptibility weighted and MR perfusion imaging abnormality.
Topics: Acetazolamide; Anticonvulsants; Brain; Child; Female; Hemiplegia; Humans; Magnetic Resonance Angiogr | 2010 |
Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience.
Topics: Acetazolamide; Adult; Aged; Anticonvulsants; CADASIL; Female; Humans; Male; Middle Aged; Migraine Di | 2012 |
The cerebral hemodynamics of headache associated with sexual activity.
Topics: Acetazolamide; Adult; Anticonvulsants; Case-Control Studies; Cerebral Cortex; Female; Headache Disor | 2003 |
[Vertigo attacks -- current therapy].
Topics: Acetazolamide; Adult; Aged; Betahistine; Dexamethasone; Ear, Middle; Gentamicins; Humans; Injections | 2005 |
A case of intermittent ataxia associated with migraine headaches.
Topics: Acetazolamide; Adult; Anticonvulsants; Ataxia; Diagnosis, Differential; Female; Humans; Migraine Dis | 2007 |
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studie | 1996 |
Cerebrovascular reactivity measured by transcranial Doppler in migraine.
Topics: Acetazolamide; Adult; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circulation; Female; H | 1996 |
Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Chronic Disease; Female; Headache; Humans; Intracranial Pressure; Middle Aged; | 1996 |
Acetazolamide responsiveness in familial hemiplegic migraine.
Topics: Acetazolamide; Adult; Brain; Cerebellar Ataxia; Female; Hemiplegia; Humans; Magnetic Resonance Imagi | 1996 |
Acetazolamide-responsive migraine in CADASIL.
Topics: Acetazolamide; Cerebral Arterial Diseases; Dementia, Multi-Infarct; Genes, Dominant; Humans; Leukoen | 1998 |
A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia.
Topics: Acetazolamide; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Animals; Brain; Calcium Ch | 1999 |
Acetazolamide for the treatment of migraine with aura in CADASIL.
Topics: Acetazolamide; Adult; Brain; Dementia, Multi-Infarct; Diagnosis, Differential; Female; Homeostasis; | 2001 |
Quantitative assessment of blood flow reserve using 99mTc-HMPAO in carotid stenosis.
Topics: Acetazolamide; Adult; Aged; Carotid Stenosis; Case-Control Studies; Cerebrovascular Circulation; Fem | 2002 |
The influence of acetazolamide on cerebral low-flow regions in migraine--an interictal 99mTc-HMPAO SPECT study.
Topics: Acetazolamide; Adult; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Migraine Disor | 1992 |
[Alternating hemiplegia in childhood. Clinical report and single photon emission computed tomography study].
Topics: Acetazolamide; Aspirin; Brain Ischemia; Cerebral Cortex; Child, Preschool; Chloral Hydrate; Drug The | 1988 |